Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Merck & Co

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    EXCIPIENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Expert Take on CEP 2.0: A New Era of Transparency in Pharmaceutical Regulation

    micExpert Take on CEP 2.0: A New Era of Transparency in Pharmaceutical Regulation

    At the recent EDQM conference “Certified for Success: Using the CEP Procedure to Elevate Quality and Drive Trust,” regulatory leaders gathered to discuss one of the most significant shifts in European pharmaceutical oversight recently– the transition to CEP 2.0. In the following article, Karina Boszko, Head of Global Regulatory Affairs and Customer Technical Service at Polpharma API, shares her perspective on the new framework and its impact on transforming regulatory strategies for manufacturers worldwide. A strategic shift beyond just compliance. CEP 2.0 is more than a routine update. It represents a fundamental change in how pharmaceutical companies approach transparency, lifecycle management, and international expansion. Rather than focusing solely on documentation, the framework encourages organizations to treat regulatory excellence as a strategic differentiator, shifting the mindset from static compliance to continuous lifecycle oversight. Regulatory alignment thus becomes a living process that evolves with the product, data, and technology. Embedding this approach across teams will foster a culture of iterative improvement, innovation, and stronger organizational resilience. For many manufacturers, however, this will require introducing significant internal changes, from documentation practices to cross-functional collaboration. CEP 2.0 means faster timelines and higher predictability. But only if your team is ready. One of the most anticipated benefits of CEP 2.0 is more predictable review timelines and consistent submissions. However, leveraging these advantages depends heavily on industry readiness. Regulatory teams must adapt to more streamlined, data-driven processes and ensure that digital tools, training, and workflows support accelerated operations. Organizations that modernize will see multiple operational benefits early, including faster project completion, reduced rework, and quicker access to key markets as standardized documentation and cohesive global expectations will make previously complex or "slow” markets more accessible. For companies pursuing international expansion, CEP 2.0 provides a clearer path to global approvals, cross-market consistency, and enhanced competitiveness. Balancing challenges with opportunity. Despite its promise, the transition to CEP 2.0 is not without challenges. Data privacy, operational costs, supply chain complexity, and pressure on low-margin APIs remain key industry concerns that require striking a balance between stringent compliance and long-term sustainability. Still, companies that efficiently integrate regulatory requirements into scalable operations will not only demonstrate the maturity of their quality systems but also build trust externally, strengthening their reputation and differentiating their business in an increasingly competitive market. Looking ahead to a more collaborative future. CEP 2.0 positions the pharmaceutical sector for a future where regulatory excellence drives global competitiveness. Transparency, harmonization, and a lifecycle approach will increasingly define market leaders. The framework’s success, however, requires ongoing dialogue with regulators. Clear, practical guidance from the EDQM, combined with active feedback from manufacturers, is essential. The more open the collaboration, the more effectively CEP 2.0 will support innovation, quality, and patient safety. The question for every organization is how to approach this moment: as a compliance burden, or as a strategic opportunity to elevate quality, accelerate growth, and build long-term trust. Connect with Polpharma API: Your Partner in Pharma AdvancementFor more information on how Polpharma API can be your strategic ally in drug substance development and manufacturing, contact us at api@polpharma.comLet's embark on a journey of innovation and excellence together.

    Impressions: 147

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/expert-take-on-cep-2-0-a-new-era-of-transparency-in-pharmaceutical-regulation

    PharmaCompass
    13 Feb 2026
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaSmart & Innovative Custom ManufacturingSmart & Innovative Custom Manufacturing

    Smart & Innovative Custom Manufacturing
    Smart & Innovative Custom Manufacturing

    reelSmart & Innovative Custom Manufacturing

    This PharmaReel highlights PMC Isochem, a smart custom manufacturing partner that offers Generic APIs, cGMP Intermediates, Vitamin E TPGS, and cutting-edge drug delivery materials, supported by trusted CDMO & CRO services and certified by the USFDA and EDQM.

    Impressions: 96

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

    FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

    This week, PharmaCompass brings you key highlights of the US Food and Drug Administration’s December 2025 list of Off-Patent, Off-Exclusivity Drugs (OPOE) without an approved generic. The OPOE list gets updated every six months.This list highlights drug products that have lost patent protection and regulatory exclusivity, but remain without approved generic competition in the US market. With this list, the FDA hopes to bolster competitiveness in the generics market, improve transparency and encourage the development and submission of abbreviated new drug applications (ANDAs) in markets with little competition.Since December 2021, FDA has been publishing two versions of the OPOE list — one for prescription (Rx) drug products and the other for over-the-counter (OTC) drug products that are approved and marketed under a new drug approval (NDA).  Access the Interactive Dashboard on FDA's December 2025 List of OPOE Drugs (Free Excel)Injectables continue to dominate FDA’s OPOE Rx list; 73 OTC drugs figure in Dec listFDA’s December 2025 OPOE Rx list includes 784 drug products that currently have no approved generics. Out of these, 296 are injectables and 126 are oral solid dosage forms (such as tablets, capsules and modified release forms). In June 2025, the OPOE Rx list had 765 drug products without an approved generic, out of which 304 were injectables, while 109 were oral solid drug forms. The increase in drug products from 765 to 784 from June 2025 to December 2025 was due to the inclusion of additional dosage strengths in the OPOE Rx list. Otherwise, no new drugs were added to the December 2025 OPOE Rx list.The December 2025 OPOE list has 73 OTC drugs, slightly higher than the 69 drugs in the June 2025 list. Among the 73, 21 are oral solid dosage forms.Among the OTC drugs on the December 2025 OPOE list are ibuprofen and ibuprofen sodium (for pain and inflammation), pseudoephedrine hydrochloride and phenylephrine hydrochloride (nasal decongestants), nizatidine and famotidine (for gastroesophageal reflux disease), loratadine, cetirizine hydrochloride and chlorpheniramine maleate (for allergy relief), loperamide hydrochloride (anti-diarrheal), and orlistat (for weight management). Access the Interactive Dashboard on FDA's December 2025 List of OPOE Drugs (Free Excel)FDA fast-tracks initiatives to accelerate market entry of generics, biosimilarsFDA has launched several regulatory initiatives designed to accelerate the market entry of generics and biosimilars. In October 2025, the agency announced a new pilot prioritization program for the review of ANDAs that aims to encourage and reward investment in drug manufacturing, research and development and strengthen the pharmaceutical supply chain in the United States.Separately, FDA has also come out with a new draft guidance that seeks to simplify biosimilarity studies and reduce unnecessary clinical testing. Through a separate initiative, the agency also plans to make it easier for biosimilars to be developed as interchangeable with brand-name biologics, thereby helping patients and pharmacists choose lower-cost options. Access the Interactive Dashboard on FDA's December 2025 List of OPOE Drugs (Free Excel) Our viewThe global generic drugs market was valued at US$ 445.62 billion in 2024 and is projected to reach US$ 728.64 billion by 2034, growing at a compound annual growth rate of 5.04 percent from 2025 to 2034. With several diabetes, immunology, oncology and cardiology drugs slated to face patent expirations this year, and continued pressure on drugmakers to improve affordability, we believe the generic market could grow at an even faster rate in the near term.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 1607

    https://www.pharmacompass.com/radio-compass-blog/fda-opoe

    #PharmaFlow by PHARMACOMPASS
    22 Jan 2026
    Share Share

    NEWS #PharmaBuzz

    [Sponsored by another company]read-more
    read-more
    Keytruda Combo Approved for Platinum-Resistant Ovarian Cancer
    Keytruda Combo Approved for Platinum-Resistant Ovarian Cancer

    12 Feb 2026

    // FDA

    https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-paclitaxel-platinum-resistant-epithelial-ovarian-fallopian-tube-or

    FDA
    12 Feb 2026
    Share Share
    Merck Teams Up With British Medtech Calla Lily
    Merck Teams Up With British Medtech Calla Lily

    10 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/merck-teams-british-medtech-boost-vaginal-therapeutics-delivery-system

    FIERCE BIOTECH
    10 Feb 2026
    Share Share
    Immutep Reaches 50% Enrollment In Global Phase III Trial For 1L
    Immutep Reaches 50% Enrollment In Global Phase III Trial For 1L

    06 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/06/3233774/0/en/Immutep-Achieves-50-Enrolment-in-Global-TACTI-004-KEYNOTE-F91-Phase-III-Trial-in-1L-NSCLC.html

    GLOBENEWSWIRE
    06 Feb 2026
    Share Share
    Merck lines up $70B+ in revenue opportunities over next decade
    Merck lines up $70B+ in revenue opportunities over next decade

    03 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/merck-confident-post-keytruda-future-70b-opportunity-next-decade-growth-drivers

    FIERCE PHARMA
    03 Feb 2026
    Share Share
    Merck Announces 2025 Financial Results, Pipeline Progress
    Merck Announces 2025 Financial Results, Pipeline Progress

    03 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-03/merck-co-inc-rahway-nj-usa-announces-fourth-quarter-and-full-year-2025-financial-results

    PHARMIWEB
    03 Feb 2026
    Share Share
    NMPA Approves Promega MSI Kit as KEYTRUDA Companion Diagnostic
    NMPA Approves Promega MSI Kit as KEYTRUDA Companion Diagnostic

    03 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-03/china-nmpa-approves-promega-msi-detection-kit-as-companion-diagnostic-for-keytruda

    PHARMIWEB
    03 Feb 2026
    Share Share
    Contact Merck & Co and get a quotation

    Merck & Co is a supplier offers 145 products (APIs, Excipients or Intermediates).

    Find a price of Betamethasone bulk with DMF offered by Merck & Co

    Find a price of Ivermectin bulk with CEP offered by Merck & Co

    Find a price of Loratadine bulk with CEP offered by Merck & Co

    Find a price of 2-Methoxyestradiol bulk offered by Merck & Co

    Find a price of 5-N,N-Dibenzylglycyl-Salicylamide bulk offered by Merck & Co

    Find a price of Arprinocid bulk offered by Merck & Co

    Find a price of Brompheniramine Maleate bulk offered by Merck & Co

    Find a price of Butorphanol Tartrate bulk offered by Merck & Co

    Find a price of CAS 50-28-2 bulk offered by Merck & Co

    Find a price of Chlorpheniramine Maleate bulk offered by Merck & Co

    Find a price of Conjugated Estrogens bulk offered by Merck & Co

    Find a price of Corticosterone bulk offered by Merck & Co

    Find a price of Danazol bulk offered by Merck & Co

    Find a price of Desogestrel bulk offered by Merck & Co

    Find a price of Dexamethasone bulk offered by Merck & Co

    Find a price of Dexamethasone Sodium Phosphate bulk offered by Merck & Co

    Find a price of Dexbrompheniramine Maleate bulk offered by Merck & Co

    Find a price of Dexchloropheniramine Maleate bulk offered by Merck & Co

    Find a price of Diethylstilbestrol bulk offered by Merck & Co

    Find a price of Diflunisal bulk offered by Merck & Co

    Find a price of Dihydrotestosterone bulk offered by Merck & Co

    Find a price of Diltiazem bulk offered by Merck & Co

    Find a price of Droperidol bulk offered by Merck & Co

    Find a price of Edrophonium Chloride bulk offered by Merck & Co

    Find a price of Enalapril Maleate bulk offered by Merck & Co

    Find a price of Estradiol bulk offered by Merck & Co

    Find a price of Estriol bulk offered by Merck & Co

    Find a price of Estrovarin bulk offered by Merck & Co

    Find a price of Ethinyl Estradiol bulk offered by Merck & Co

    Find a price of Fentanyl Citrate bulk offered by Merck & Co

    Find a price of Fluphenazine Decanoate bulk offered by Merck & Co

    Find a price of Heparin Sodium bulk offered by Merck & Co

    Find a price of Hyaluronic Acid bulk offered by Merck & Co

    Find a price of Imipramine Hydrochloride bulk offered by Merck & Co

    Find a price of Lovastatin bulk offered by Merck & Co

    Find a price of Medroxyprogesterone Acetate bulk offered by Merck & Co

    Find a price of Megestrol Acetate bulk offered by Merck & Co

    Find a price of Mestranol bulk offered by Merck & Co

    Find a price of Mk-6240 bulk offered by Merck & Co

    Find a price of Mk2048 bulk offered by Merck & Co

    Find a price of Nalbuphine Hydrochloride bulk offered by Merck & Co

    Find a price of Nalmefene Hydrochloride bulk offered by Merck & Co

    Find a price of Naltrexone bulk offered by Merck & Co

    Find a price of Neomycin Sulfate bulk offered by Merck & Co

    Find a price of Norandrostenedione bulk offered by Merck & Co

    Find a price of Norethisterone bulk offered by Merck & Co

    Find a price of Norethisterone Acetate bulk offered by Merck & Co

    Find a price of Norgestimate bulk offered by Merck & Co

    Find a price of Omeprazole Magnesium bulk offered by Merck & Co

    Find a price of Oxandrolone bulk offered by Merck & Co

    Find a price of Oxytocin bulk offered by Merck & Co

    Find a price of Pheniramine Maleate bulk offered by Merck & Co

    Find a price of Pimozide bulk offered by Merck & Co

    Find a price of Prasterone Acetate bulk offered by Merck & Co

    Find a price of Prednisolone Sodium Phosphate bulk offered by Merck & Co

    Find a price of Prochlorperazine Edisylate bulk offered by Merck & Co

    Find a price of Promethazine Hydrochloride bulk offered by Merck & Co

    Find a price of Pyridostigmine bulk offered by Merck & Co

    Find a price of Testosterone Propionate bulk offered by Merck & Co

    Find a price of Thiabendazole bulk offered by Merck & Co

    Find a price of Tibolone bulk offered by Merck & Co

    Find a price of Tubocurarine Chloride bulk offered by Merck & Co

    Find a price of Urofollitropin bulk offered by Merck & Co

    Find a price of Vitamin B12 bulk offered by Merck & Co

    Find a price of AMPROLIUM MEDICATED FEED -(3-NITRO-4-HYDROXYPHENYLARSONIC ACID) (VET) bulk offered by Merck & Co

    Find a price of PRO-STREP CRUMBLES (VET) bulk offered by Merck & Co

    Find a price of L-000825058 bulk offered by Merck & Co

    Find a price of MANUF. CONTROL FACILITIES & PROCEDURES FOR DANVILLE PA PLANT bulk offered by Merck & Co

    Find a price of HADACIDIN SOD. DIHYDRATE (NSC 521778) & HADACIDIN POTASS. NSC 72962 bulk offered by Merck & Co

    Find a price of RATHDRUM, COUNTY WICKLOW, IRELAND bulk offered by Merck & Co

    Find a price of PORCINE INSULIN HIGHLY PURIFIED bulk offered by Merck & Co

    Find a price of HYDROCORT. 21-PHOSPHATE & NEOMYCIN SO4--OPTHAL. SOL. 0.5% & INJECT bulk offered by Merck & Co

    Find a price of ORG 32489 RECOMBINANT FSH bulk offered by Merck & Co

    Find a price of CORTATE (DESOXYCORTICOSTERONE ACETATE) bulk offered by Merck & Co

    Find a price of MANUFACTURE AND CONTROL bulk offered by Merck & Co

    Find a price of PROCESS $ CONTROL DATE CONCERNING MANUFACTURE OF 2-ACETYLAMINA ETC. bulk offered by Merck & Co

    Find a price of L-651,392-00N,4-BROMO-2,7-DIMETHOXY-3H-PHENOTHIAZIN-3-ONE bulk offered by Merck & Co

    Find a price of J-107088 bulk offered by Merck & Co

    Find a price of 1-METHYL-1-(B-CHLOROETHYL) ETHYLENIMONIUM PICRYSULFONATE bulk offered by Merck & Co

    Find a price of MANUF, CONTROL FACILITIES PROCEDURES FOR ALBANY, GA. PLANT bulk offered by Merck & Co

    Find a price of BULK FORM OF DRUG PRODUCT L-590,153 PROCESSED RAHWAY, N.J. FACILITIES bulk offered by Merck & Co

    Find a price of MERCK bulk offered by Merck & Co

    Find a price of NORGESTOMET bulk offered by Merck & Co

    Find a price of FACILS., METHODS & CONTROLS FOR PROCESSING & PACKAGING OF DRUG PRODS. bulk offered by Merck & Co

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN LE PUY CEDEX, FRANCE. bulk offered by Merck & Co

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN OKAZAKI CITY, JAPAN. bulk offered by Merck & Co

    Find a price of PRO-STREP IN SWINE (VET) bulk offered by Merck & Co

    Find a price of TECHNETIUM Tc 99M POLYPHOSPHATE KIT bulk offered by Merck & Co

    Find a price of MANUF&CONTROL FACILITIES&PROCEDURES AT SUBSIDIARY PLANT BARCELONETA,PR bulk offered by Merck & Co

    Find a price of AMPROLIUM IN CHICKENS (VET) bulk offered by Merck & Co

    Find a price of AMPROL SUPER PLUS (AMPROLIUM & ETHOPABATE) (VET) bulk offered by Merck & Co

    Find a price of MANUF. & CONTROL,FACILITIES & PROCEDURES-FOR ELKTON, VA. PLANT bulk offered by Merck & Co

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN HOBBESDON, HERFORDSHIRE, ENGLAND. bulk offered by Merck & Co

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN WILSON, NORTH CAROLINA. bulk offered by Merck & Co

    Find a price of MANUF.CONTROL,FACILITIES &PROCEDURES-AT RAHWAY, NJ PLANT bulk offered by Merck & Co

    Find a price of PREPARATION OF TEN STABLE ISOTOPE-LABELLED COMPOUNDS bulk offered by Merck & Co

    Find a price of STERILE DILUENT bulk offered by Merck & Co

    Find a price of MK-4176 DRUG SUBSTANCE bulk offered by Merck & Co

    Find a price of FACILITY AND PROCEDURES IN OSS, THE NETHERLANDS - MOLENSTRAAT 110 bulk offered by Merck & Co

    Find a price of FACILITIES AND OPERATING PROCEDURES IN CLERMONT-FERRAND,FRANCE bulk offered by Merck & Co

    Find a price of NITROGEN MUSTARDS bulk offered by Merck & Co

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES. bulk offered by Merck & Co

    Find a price of Aprepitant bulk offered by Merck & Co

    Find a price of Avobenzona bulk offered by Merck & Co

    Find a price of Betamethasone Sodium Phosphate bulk offered by Merck & Co

    Find a price of Boceprevir bulk offered by Merck & Co

    Find a price of Boric Acid bulk offered by Merck & Co

    Find a price of CAS 532-40-1 bulk offered by Merck & Co

    Find a price of CAS 654671-77-9 bulk offered by Merck & Co

    Find a price of CAS 66376-36-1 bulk offered by Merck & Co

    Find a price of Caspofungin bulk offered by Merck & Co

    Find a price of Cilastatin bulk offered by Merck & Co

    Find a price of Cilastatin Sodium bulk offered by Merck & Co

    Find a price of Cocarboxylase bulk offered by Merck & Co

    Find a price of Cocarboxylase Tetrahydrate bulk offered by Merck & Co

    Find a price of Desloratadine bulk offered by Merck & Co

    Find a price of Doravirine bulk offered by Merck & Co

    Find a price of Elbasvir bulk offered by Merck & Co

    Find a price of Ensulizole bulk offered by Merck & Co

    Find a price of Ertapenem bulk offered by Merck & Co

    Find a price of Ezetimibe bulk offered by Merck & Co

    Find a price of Fenbendazole bulk offered by Merck & Co

    Find a price of Florfenicol bulk offered by Merck & Co

    Find a price of Flunixin Meglumine bulk offered by Merck & Co

    Find a price of Gentamicin Sulfate bulk offered by Merck & Co

    Find a price of Grazoprevir bulk offered by Merck & Co

    Find a price of Imipenem bulk offered by Merck & Co

    Find a price of Letermovir bulk offered by Merck & Co

    Find a price of Loratadine bulk offered by Merck & Co

    Find a price of Meglumine bulk offered by Merck & Co

    Find a price of Metformin bulk offered by Merck & Co

    Find a price of Milbemycin Oxime bulk offered by Merck & Co

    Find a price of Montelukast Sodium bulk offered by Merck & Co

    Find a price of Posaconazole bulk offered by Merck & Co

    Find a price of Potassium Phosphate bulk offered by Merck & Co

    Find a price of Raltegravir Potassium bulk offered by Merck & Co

    Find a price of Simvastatin bulk offered by Merck & Co

    Find a price of Sitagliptin Phosphate bulk offered by Merck & Co

    Find a price of Sodium Fluoride bulk offered by Merck & Co

    Find a price of Suvorexant bulk offered by Merck & Co

    Find a price of Trisodium Citrate Dihydrate bulk offered by Merck & Co

    Find a price of Zinc Oxide bulk offered by Merck & Co

    Find a price of MANUFACTURING OPERATIONS bulk offered by Merck & Co

    Find a price of LUPROSTIOL bulk offered by Merck & Co

    Find a price of MANUFACTURING OPERATIONS, FILLING LINES 1 AND 2 bulk offered by Merck & Co

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.